Wireless signals could diagnose brain swelling; Regulatory risk could dampen med tech investment;

@FierceMedDev: New special report: After tough times, hip implant revenue projected to grow again. Feature | Follow @FierceMedDev

@MarkHFierce: Roche may be selling its glucose meter business, Reuters reports--blame competition and worsening reimbursement. Story | Follow @MarkHFierce

 @DamianFierce: In case you missed it: Hospira endured another FDA warning letter, this time over the pumps it wants to keep. Article | Follow @DamianFierce

> Saudi surgeons say they've successfully implanted electrodes for a cochlear implant into the brainstem of a 3-year-old child. Story

> Illumina ($ILMN) has launched BaseSpace, a cloud-based computing and storage platform for genomic data. News

> Despite accounting for only 0.6% of the global medical device market, Israel is No. 1 in device patents per capita, a sign that the country's local industry is on the rise. Article

> A team at the University of California in Berkeley has come up with a system of wireless signals to provide, quick, efficient and accurate non-invasive diagnoses of brain swelling or bleeding. Item

> An EU court has clarified the meaning of the term "medical device" as part of an ongoing legal case. Item

> Regulatory risk is preventing more med tech investment, an industry panel recently argued in Sacramento. Story

> Europe's dive into recession could cause more struggles for devicemakers down the line. Story

Biotech News

@FierceBiotech: In case you missed it last night: Scientists use cloning method to create embryonic stem cells. Article | Follow @FierceBiotech

@JohnCFierce: Roche's next-gen Rituxan candidate impresses in first look at PhIII data. Report | Follow @JohnCFierce

@RyanMFierce: @SanofiUS hunts for clinical trial recruits in growing social network. Article | Follow @RyanMFierce

> AstraZeneca revs up PhIII cancer plans as rivals steal ASCO spotlight. News

> Gilead speeds ahead on idelalisib with promising leukemia data. Story

> Amgen, Novartis aim to fuel biotech startups in alliance with Atlas Venture. Article

Pharma News

@FiercePharma: AstraZeneca advances three cancer drugs into late-stage trials. Story | Follow @FiercePharma

@EricPFierce:  Pfizer to give privileges to small group of contract manufacturers as it makes network more efficient. Article | Follow @EricPFierce

> WSJ: Novartis sniffs around $16B offer for Actavis. Article

> Novartis properly warned of Zometa's risks, jury decides. Story

> Colitis nod puts J&J's Simponi one step closer to blockbuster. More

Pharma Manufacturing News

> CEO of J&J OTC unit in Korea faces criminal action over plant foul-up. News

> Recalls jump 32% in first quarter. Article

> Pfizer to close Ireland plant by next year. Story

> Pfizer to pick some contract manufacturers for new elevated role. More

Vaccines News

> Taliban drops campaign against polio vaccine. News

> Human-to-human coronavirus spread looks likely. Item

> Cash injection raises hopes of diabetes vaccine. More

> Media reports used to track global vaccine backlash. Article

> Indian rotavirus vax set to undercut GSK and Merck. Story

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.